SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company's financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as CFO of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.
SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible globally. Its product range includes the proprietary SSi Mantra surgical robotic system and a suite of SSi Mudra surgical instruments, supporting various procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its cost-effective surgical robotic solutions.
The appointment signals SSII's commitment to strengthening its financial leadership as it pursues regulatory milestones. Romano's experience in raising capital and managing public company finances will be crucial as the company seeks FDA clearance and expands its market reach. The full press release is available at https://ibn.fm/pAqlP. For more information about the company, including terms of use and disclaimers, visit http://IBN.fm/Disclaimer.
